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ABSTRACT

Background
Sensenbrenner syndrome is a ciliopathy that is characterized by skeletal and ectodermal anomalies, accompanied by chronic renal failure, heart defects, liver fibrosis and other features.
Methods
SNP array analysis and standard sequencing techniques were applied to identify the causative gene. The effect of the identified mutation on protein translation was determined by western blot analysis. Antibodies against intraflagellar transport (IFT) proteins were used in ciliated fibroblast cell lines to investigate the molecular consequences of the mutation on ciliary transport.
Results
We performed homozygosity mapping and positional candidate gene sequence analysis in two siblings with Sensenbrenner syndrome of a consanguineous Moroccan family. In both siblings, we identified a homozygous mutation in the initiation codon of C14ORF179. C14ORF179 encodes IFT43, a subunit of the intraflagellar transport complex A (IFT-A) machinery of primary cilia. Western blots revealed that the mutation disturbs translation of IFT43, inducing the initiation of translation of a shorter protein product from a downstream ATG. The IFT-A protein complex is implicated in retrograde ciliary transport along axonemal microtubules. We show that in fibroblasts of one of the by Sensenbrenner affected siblings, disruption of IFT43 disturbs this transport from the ciliary tip to its base. As anterograde transport in the opposite direction apparently remains functional, the intraflagellar transport complex B proteins accumulate in the ciliary tip. Interestingly, we obtained similar results 4 using fibroblasts from a Sensenbrenner syndrome patient with mutations in WDR35/IFT121, encoding another IFT-A subunit.
Conclusions
Our results indicate that Sensenbrenner syndrome results from disrupted IFT-A mediated retrograde ciliary transport.
INTRODUCTION
Sensenbrenner syndrome or cranioectodermal dysplasia (CED; MIM 218330) is a rare autosomal-recessive heterogeneous ciliopathy that is primarily characterized by skeletal abnormalities (e.g. craniosynostosis, narrow rib cage, short limbs, brachydactyly) and ectodermal defects. [1, 2] Nephronophthisis leading to progressive renal failure, hepatic fibrosis, heart defects, and retinitis pigmentosa have also been described. [3] [4] [5] [6] Recently, mutations in two genes have been found to cause Sensenbrenner syndrome, IFT122 (encoding intraflagellar transport protein 122; MIM 606045) and WDR35 (encoding WD repeat-containing protein 35; MIM 613602). [7, 8] Both genes encode proteins that are part of the intraflagellar transport (IFT) complex A (IFT-A). This multisubunit complex, consisting of at least six proteins, forms the core of a particle that is mobilized by the cytoplasmic dynein/dynactin motor. The IFT-A particles use the microtubule bundles of the ciliary axoneme to carry membrane vesicles and other "cargo" proteins from the tip of a cilium to its base (retrograde IFT). [9, 10] Both retrograde and anterograde IFT (transport towards the ciliary tip), are required for ciliary assembly, disassembly and homeostasis. [9] [10] [11] 
METHODS
SNP array analysis
Genomic DNA was isolated from peripheral blood samples of two siblings with Sensenbrenner syndrome and their parents. Each DNA sample was genotyped with an Affymetrix 250K NspI array (Affymetrix, Santa Clara, CA, USA), which contains 262,000 SNPs. Array experiments were conducted according to protocols from the manufacturer. The 250K SNP genotypes were analyzed with Genotyping Console 6 software (Affymetrix). PLINK [12] (available online) was used for calculation of regions of homozygosity.
Mutation analysis
Candidate genes were sequenced using patient genomic DNA. Primers for C14ORF179 and TTC8 were designed with the Primer 3 program (freely available online); primer sequences are listed in Supplemental Table 3 . All coding exons of C14ORF179 and TTC8 were amplified by PCR and analyzed forward and reverse with a dye-termination chemistry (BigDye Terminator, version 3 on a 3730 DNA analyzer; Applied Biosystems). PCR conditions are available upon request.
DNA constructs
A full length cDNA clone (IRAUp969A1256 from ImaGenes) was used as a template to amplify full length C14ORF179 (NM_052873, isoform 1) with Gateway compatible primers. A consensus kozak sequence "gccgccacc" or a C14ORF179 5'UTR fragment "gtttccaggaagtgacgtcaggcggccgcggag" was included in the forward primers, just prior to the "atg". PCR products were used to create Gateway-adapted constructs by using the Gateway cloning system (Invitrogen). C14ORF179 was then cloned into two vectors, the Gateway-adapted SF-TAP vector (with a C-terminal Strep II-FLAG-tag) [13] and p504 (with a C-terminal eYFP tag). [14] Wild type constructs and vectors containing the translation initiation codon mutation were made. 
Transfection and western blot analysis
Immunocytochemistry
Fibroblast cells from Sensenbrenner patients (CL10-00031 and CL10-00021) and a control individual (CL10-00010) were stained with antibodies to the following proteins: IFT88 and IFT57 (rabbit polyclonal; both kindly provided by G. Pazour;
1:300 and 1:250, respectively); GT335 (mouse monoclonal; kindly provided by C. Janke; 1:1500); RPGRIP1L (guinea pig polyclonal; SNC040, 1:500), [14] and acetylated alpha-tubulin (mouse monoclonal, Zymed laboratories, 1:1000). The secondary antibodies (all from Molecular Probes) that were used are as following: Images were processed with AxioVision (Zeiss) and Photoshop CS4 (Adobe Systems).
Accession numbers and web resources
Accession numbers of the C14ORF179 gene and a list of the web resources that were used in this study can be found in Supplementary Materials and Methods.
RESULTS
Clinical studies and genotyping
To identify additional genetic defects underlying Sensenbrenner syndrome, we conducted genome-wide homozygosity mapping by using Affymetrix 250K arrays in a consanguineous family from Moroccan descent with two siblings with Sensenbrenner syndrome (family P05-1040, Figure 1 and Supplemental Table 1 ).
Homozygosity analysis by using PLINK [12] revealed that the largest-and secondlargest homozygous regions of the affected siblings from family P05-1040 9 (individuals II:1 and II:2, Table 1 ) are overlapping; this region was 25.2 Mb on chromosome 14 (containing 158 annotated RefSeq genes), with SNP_A-2107558 and SNP_A-2312334 as bordering SNPs (Figure 1 , Table 1 and Supplementary Table 2 ).
Other homozygous regions shared less overlap, indicating that the genetic defect was most likely to be found in the region on chromosome 14 that contains the genes C14ORF179 and TTC8.
Given that IFT122 and WDR35, which are both associated with Sensenbrenner syndrome, are part of the IFT-A protein complex, we selected C14ORF179 as our primary candidate, as this gene encodes the human orthologue of another member of the IFT-A complex, IFT43. [9, 10] In addition, we selected TTC8 (tetratricopepteide repeat domain 8; MIM 608132) as a candidate gene. This gene encodes an IFT regulator and is disrupted in Bardet-Biedl syndrome (BBS; MIM 209900). [15, 16] 
Mutation detection
Sequence analysis of candidate genes TTC8 and C14ORF179 in the affected siblings excluded genetic defects in TTC8 as a cause of Sensenbrenner syndrome in these patients, but did reveal a homozygous variation in the translation initiation codon in exon 1 of C14ORF179 (c.1A>G) (Figure 2A ). This variation cosegregates with the disorder in the family, as both (related) parents are heterozygous for this variation (Figure 2A ). The c.1A>G variant was neither present in dbSNP, nor in 192 Dutchand 122 Moroccan control alleles, respectively, which provides further evidence for the pathogenicity of the identified mutation.
In an attempt to identify more mutations in C14ORF179, we screened this gene for mutations in four unrelated Sensenbrenner patients who did not carry WDR35 mutations. We did not identify mutations in these patients. Since homozygosity 1 0 mapping in patients from two consanguineous Sensenbrenner families did not reveal major stretches of homozygosity in the regions containing WDR35, IFT122 or C14ORF179, it is likely that the heterogeneity in Sensenbrenner syndrome extends beyond these three genes.
C14ORF179 mutation causes aberrant translation of the encoded IFT43 protein
C14ORF179 contains 10 exons that encode two major protein isoforms derived from alternative splicing that only vary in a central segment of both isoforms ( Figure 2B -C). Although ATG>GTG mutations have been reported to be pathogenic (e.g. in hereditary osteodystrophy, [17] Norrie disease, [18] and beta-thalassemia [19] ), it has also been described that the GTG codon can be used as an initiation codon, albeit rare and inefficient. [20] [21] [22] We therefore investigated the effect of the c.1A>G mutation in 
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Mutation in C14ORF179/IFT43 disrupts ciliary transport
The structure of IFT43, the protein product of C14ORF179, remains largely elusive as the protein contains no significant homology with any structural or functional motifs (as determined by using SMART [23] ) ( Figure 2C ). The protein was initially studied in Chlamydomonas reinhardtii. [9] The Chlamydomonas orthologue is part of the intraflagellar transport complex A that is involved in retrograde transport in the cilium. [9, 10] The IFT-A protein complex consists of IFT43, IFT121/WDR35, IFT122, IFT139, IFT140 and IFT144 [10] , and is associated to THM1 and TULP3. [24] Recently, it was shown that IFT43 directly binds to IFT121/WDR35, which supports a tight relationship between these two proteins. [25] This is remarkable, since IFT121/WDR35 is the protein product of WDR35, a previously identified Sensenbrenner gene. [8] Studies in multiple species, including Chlamydomonas reinhardtii, Caenorhabditis elegans, Drosophila melanogaster and Trypanosoma brucei, have shown that disruption of retrograde transport leads to formation of bulged cilia that contain an accumulation of IFT-B complex proteins in their tips. [24, [26] [27] [28] [29] [30] In order to validate the disruptive effect of the identified mutation in C14ORF179 in family P05-1040
( Figures 1 and 2) , we stained fibroblasts from one of the affected siblings (II:2) using antibodies against the IFT-B complex protein members IFT88 and IFT57. Indeed, we identified a similar accumulation of IFT-B complex proteins in the distal part of the ciliary axoneme and in the ciliary tip (Figure 3 and Supplementary Figures 1 and 2) , while in cilia of control fibroblasts, these proteins were less abundant and primarily localized at the basal body and transition zone.
2
Subsequently, we compared these ciliary defects with the phenotype of cilia in fibroblasts from a Sensenbrenner patient with WDR35 mutations (a patient that we described previously [8] ), and found nearly identical defects (Fig 3 and Supplementary   Figures 1 and 2) . Moreover, similar to what was reported for Sensenbrenner patients with IFT122 mutations, [7] we found that cilia from patient fibroblasts (II:2, Figure) are somewhat shorter than those of healthy controls ( Supplementary Figure 3) .
DISCUSSION
We report on a family with two children with Sensenbrenner syndrome who carry a mutation in the translation initiation codon of C14ORF179. This is the third gene associated with Sensenbrenner syndrome and in line with the other two genes (WDR35 and IFT122), C14ORF179 also encodes a member of the IFT-A particle (IFT43). Mutations in WDR35 can cause both Sensenbrenner syndrome and the more severe (and embryonically lethal) Short Rib-Polydactyly (personal communication, P.J. Lockheart). We therefore suggest that both syndromes are part of a phenotypic spectrum of IFT-A complex disruption, similar to what has been proposed for Joubert syndrome and allied ciliopathies like Meckel-Grüber syndrome and Bardet-Biedl syndrome. The remaining protein activity then determines the severity of the disease phenotype. Indeed, in all genes associated with Sensenbrenner syndrome identified thus far, only mutations with a relatively mild disruptive character (mainly missense mutations, sometimes in combination with a truncating mutation) were identified, including the mutation described in this report which results in a small, N-terminal truncation of IFT43. In this respect, it is interesting to note that although we show that such mild mutations in cilia of Sensenbrenner patients' fibroblasts disrupt retrograde transport, they do not abrogate ciliogenesis. and RPGRIP1L (red). Comparison of the IFT88 staining in control fibroblasts with cells from Sensenbrenner patients reveals that IFT88 accumulates in the ciliary tips of the patient's fibroblasts. Note, that there is a certain extent of variability between IFTdefects in cilia from the patients; i.e. in some cilia the IFT88 staining is more intense (and more distal) than in others. B) Fibroblasts from Sensenbrenner patients with C14ORF179 and WDR35 mutations were stained for IFT57 (an IFT-B complex protein), and two markers that stain the base of the cilium, GT335 and RPGRIP1L. IFT57 (green); GT335 (purple); and RPGRIP1L (red). Like IFT88, IFT57
accumulates in the distal ends of cilia in fibroblasts from the patients.
